4171F Pt rcvng esa thxpy
Also known as: ESA therapy measure, erythropoietin measure, EPO therapy tracking
Performance measure code indicating that a patient is receiving erythropoiesis stimulating agent therapy.
In Plain Language
red blood cell booster medication given; anemia treatment recorded; blood cell stimulating injection
Clinical Context
Quality measure for chronic kidney disease and anemia management. Tracks use of erythropoiesis stimulating agents with appropriate monitoring.
RVU Information
CPT 4171F does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Documentation should include the clinical indication, service details, and any applicable performance metrics. Coverage may vary by payer — verify acceptance before billing.
Specialties
Frequently Asked Questions
What is CPT code 4171F?
CPT 4171F (Pt rcvng esa thxpy) is a Other code. Performance measure code indicating that a patient is receiving erythropoiesis stimulating agent therapy.
Who uses CPT code 4171F?
CPT 4171F is used by Nephrology, Oncology, Internal Medicine. Quality measure for chronic kidney disease and anemia management. Tracks use of erythropoiesis stimulating agents with appropriate monitoring.
When is CPT 4171F used?
Quality measure for chronic kidney disease and anemia management. Tracks use of erythropoiesis stimulating agents with appropriate monitoring.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.